Synopsis of recent research by authors named "Xiaoxiao Ge"
- Xiaoxiao Ge's recent research predominantly focuses on neuroprotection and cancer treatment strategies, exploring innovative methods such as biodegradable stents for ischemic brain injury and novel immune checkpoint inhibitors for advanced tumors.
- Key findings include the identification of CDKN2A alterations as significant prognostic biomarkers in head and neck squamous cell carcinoma and the development of unique materials for effective sinapic acid extraction and improved cerebral cooling techniques during therapeutic hypothermia.
- The studies also address real-world evidence of immune-related adverse events in patients receiving immune checkpoint inhibitors, highlighting both the safety profiles of new therapeutics and the complex interactions of aging and blood-brain barrier integrity.
